Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease

Christian Espinoza-Vinces, Rafael Villino-Rodríguez, Ainhoa Atorrasagasti-Villar, Gloria Martí-Andrés, María-Rosario Luquin

Open source

DOI
10.2147/prom.s369590
Published
2023-10
Container
Patient Related Outcome Measures
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/prom.s369590,
  title = {Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease},
  author = {Christian Espinoza-Vinces and Rafael Villino-Rodríguez and Ainhoa Atorrasagasti-Villar and Gloria Martí-Andrés and María-Rosario Luquin},
  year = {2023},
  journal = {Patient Related Outcome Measures},
  doi = {10.2147/prom.s369590},
  url = {https://doi.org/10.2147/prom.s369590}
}

RIS

TY  - JOUR
TI  - Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease
AU  - Christian Espinoza-Vinces
AU  - Rafael Villino-Rodríguez
AU  - Ainhoa Atorrasagasti-Villar
AU  - Gloria Martí-Andrés
AU  - María-Rosario Luquin
PY  - 2023
JO  - Patient Related Outcome Measures
DO  - 10.2147/prom.s369590
UR  - https://doi.org/10.2147/prom.s369590
ER  - 

APA

Espinoza-Vinces, C., Villino-Rodríguez, R., Atorrasagasti-Villar, A., Martí-Andrés, G., & Luquin, M. (2023). Impact of Safinamide on Patient-Reported Outcomes in Parkinson’s Disease. Patient Related Outcome Measures. https://doi.org/10.2147/prom.s369590

Source records